Tesofensine 500mcg (30 Capsules)

$250.00

Tesamorelin 5mg is the synthetic 44-amino-acid stabilised GHRH analogue (Trans-3-Hexenoyl-GHRH 1-44 amide). The complete native GHRH sequence with N-terminal modification that blocks DPP-IV degradation. Greater than 99 percent HPLC verified for in-vitro adipose research only.

100 in stock

Description

Buy Tesofensine 500mcg (30 Capsules) – Peptide Science

Tesamorelin 5mg Overview

Tesamorelin 5mg from Peptide Science is the standard single-vial format of the synthetic 44-amino-acid stabilised GHRH analogue, supplied as a lyophilised powder for in-vitro and preclinical adipose / pituitary research. The compound is the full-length GHRH 1-44 sequence modified at the N-terminus with a trans-3-hexenoyl group that reduces enzymatic degradation by dipeptidyl peptidase IV.

Compound Class and Mechanism

Tesamorelin retains the complete 44-residue native GHRH sequence with the addition of a trans-3-hexenoyl group at the N-terminal tyrosine. The modification blocks the DPP-IV cleavage site between residues 2 and 3 that limits the in-vitro half-life of native GHRH, extending the active life of the analogue at the GHRH receptor. The compound is the active ingredient in the branded therapeutic Egrifta when supplied for HIV-associated lipodystrophy treatment; research-grade material supplied here is for laboratory work only. Browse the growth-hormone peptide range.

Specifications

Property Value
Compound Tesamorelin (Trans-3-Hexenoyl-GHRH 1-44 amide)
Class Stabilised GHRH analogue; GHRH-receptor agonist
Amino-acid count 44
Molecular weight approximately 5135 g/mol
Supplied form Lyophilised powder, sealed vial
Strength 5 mg per vial
Purity greater than 99 percent (HPLC and mass-spec verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For the multi-vial kit format with 10 x 2 mg vials, see Tesamorelin 2mg (10 Vial Kit).

Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in peptide-research literature.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation against the theoretical molecular weight. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Tesofensine 500mcg (30 Capsules)”